Canadian Hospital Specialties Limited Joins AdvaMed®, the World’s Leading Medical Technology Trade Association
- Canadian Hospital Specialties Limited
February 9, 2022 — Canadian Hospital Specialties Limited (CHS) announced today that it has joined the Advanced Medical Technology Association® (AdvaMed®), the world’s leading trade association representing more than 400 medical device manufacturers around the world. Read more…
Related Reading
News / AdvaMed Advancements / Artificial Intelligence (AI) / Coverage & Payment / Diabetes / Diagnostics / Digital Health / Global & Trade / Health Access / Investor Relations / Medical Imaging / Orthopedic / Regulatory Affairs / Tariffs / The MedTech Conference / Value-Based Collaborations
AdvaMed Concludes Record-Breaking MedTech Conference 2026
October 28, 2026
BOSTON—AdvaMed, the Medtech Association, concluded The MedTech Conference 2026, convening more than 4,470 attendees from 2,050 companies from 40 countries for the global medtech industry’s premier annual gathering.
News / Business Development / Diagnostics / Health Access
Scott Garrett Named 2026 Recipient of AdvaMedDx® Lifetime of Leadership & Service Award
October 19, 2026
BOSTON—AdvaMed, the Medtech Association, today announced Scott Garrett as the 2026 recipient of the AdvaMedDx Lifetime of Leadership & Service Award, honoring his more than 45 years of leadership across diagnostics, life sciences, medical products, specialty distribution, and laboratory services.
News / Business Development / Diagnostics / Health Access
AdvaMed Names Vince Forlenza 2026 Lifetime Achievement Award Winner
October 16, 2026
WASHINGTON, D.C.—AdvaMed®, the Medtech Association, today announced Vincent A. “Vince” Forlenza, former chairman and CEO of BD (Becton, Dickinson and Company), as the recipient of the 2026 AdvaMed Lifetime Achievement Award. Forlenza will receive the award during The MedTech Conference in Boston Oct. 18-21.
Global & Trade
AdvaMed® Resources for Colombia Earthquake Response
Learn how AdvaMed® member companies can support earthquake relief efforts in Columbia through medical supply donations, logistics assistance, financial contributions, and other humanitarian response initiatives.
News / Diagnostics / Medical Imaging / Regulatory Affairs
Cubresa Announces FDA 510(k) Clearance for the Cubresa BrainPET™ Scanner, Opening New Frontier in Clinical Brain Imaging
August 20, 2026
WINNIPEG, MANITOBA, CANADA, August 20, 2026 /EINPresswire.com/ — Cubresa Inc., a global leader in clinical and preclinical molecular imaging technologies, today announced that it has received FDA 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking Cubresa BrainPET™ scanner.
News / Diagnostics / Digital Health / Government & Legislative Affairs / Regulatory Affairs
AdvaMed Statement on the Nomination of Dr. Heidi Overton as FDA Commissioner
August 19, 2026
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the medtech association, made the following comment on President Trump’s nomination of Dr. Heidi Overton to serve as FDA commissioner.
Blog / Global & Trade / Health Access
Memory Chip Shortages: Implications for Medtech Innovation and Patient Care
August 17, 2026
Global memory chip shortages are creating growing challenges for the medical technology sector. These disruptions could affect timely patient care and innovation, underscoring the need for collaboration with memory chip suppliers and federal partners to safeguard access to essential medical technologies.
Event / Global & Trade / Regulatory Affairs
Entering the Japanese Medical Device Market: Regulatory Pathways, Consultation Opportunities, and Practical Insights
September 1, 2026 |
7:00 PM – 8:30 PM ET
September 2, 2026 |
8:00 AM – 9:30 AM JST
Learn how to enter Japan’s medtech market with insights on regulatory pathways, consultation services, and practical insights for U.S. medtech companies.